Zymeworks ZYME Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's effective income tax rate reconciliation, tax credit, research, amount?
- Zymeworks (ZYME) reported effective income tax rate reconciliation, tax credit, research, amount of $775.5K in Q4 2024.
- How has Zymeworks's effective income tax rate reconciliation, tax credit, research, amount changed year-over-year?
- Zymeworks's effective income tax rate reconciliation, tax credit, research, amount increased by 16.6% year-over-year, from $665.25K to $775.5K.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- This metric quantifies the tax benefits derived from research and development tax credits, which reduce the company's overall income tax liability. For clinical-stage companies, this is a critical indicator of government support for innovation. It highlights the company's ability to leverage R&D spending to improve its net financial position.